Taking a Break After 100 Cycles of Bevacizumab

The last patient on the ECOG-2100 trial has stopped therapy after 100 cycles, and Dr. Kathy Miller reminds clinicians to treasure the exceptions for they can point the direction to new interventions.
Source: Medscape Pharmacists Podcast - Category: Drugs & Pharmacology Authors: Source Type: podcasts